“IMPERIUM”: The No. 1 Investment of the 2020s

Important information about your income Below is an important message from our trusted sponsors  Wall Street Elites Collude With Media To Cover Up Breakthrough Discovery? Scientists just uncovered a “test tube miracle” that will revolutionize the marijuana industry. But the media has been strangely silent about it. Don’t let Wall Street insiders’ step on you again. Every $1,000 stake could turn into $61,770… but only if you take action before this discovery hits the evening news. [Click here for details.](  ---------------------------------------------------------------  Top Tech Firm Prepares to Launch New U.S. Currency In a surprising twist, one of America’s top tech firms is set to issue its own version of the U.S. dollar and kick off a new boom in privately issued money. [Click here for the surprising story](  ---------------------------------------------------------------  “I’ll review your next trade idea practically for FREE!” Hey there. Millionaire Trader - Markay Latimer - is hosting a LIVE trading call this monday at 12 PM EST where she will… - Review your next trade idea for the best entry and exit… - Warn you if you should avoid it and focus on another trade idea instead... - Share her most red-hot stocks that are set up to go on an epic run… You can get access to this LIVE trading call practically for FREE... [...Once you click this link](  ---------------------------------------------------------------  “IMPERIUM”: The No. 1 Investment of the 2020s It’s a technology I call “Imperium.” And it’s about to spark the biggest investment mega trend in history … with one small Silicon Valley company at the center of it all. [To get all the details, click here now…](  ---------------------------------------------------------------  The #1 Biotech Stock to Own Today One tiny biotech invented a breakthrough Leukemia treatment. This new medicine targets patients by their genetic profile. This new discovery threatens Big Pharma companies Bristol Meyers and Novartis. That makes this small biotech our top takeover target this month. [Find out the rest of the story here](  ---------------------------------------------------------------  Advertisement: This is a paid advertisement from a 3rd party advertiser, for a product or service that is not offered, recommended or endorsed by us and for which claims have not been independently verified. Content: All of the content on our website and in our emails is for informational and illustrative purposes only, and should not be construed as an offer, or solicitation of an offer to buy or sell securities. You should always consult with a licensed securities professional before purchasing or selling securities. 7322437 Canada (DBA as Financial Media Marketing) (collectively, the “Company” or “we” used herein) bears no responsibility or control over the content of the advertisement and/or the product or service offered. Results: Any results shown are strictly hypothetical, and were executed in simulated trading accounts. CFTC RULE 4.41 - HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING. ALSO, SINCE THE TRADES HAVE NOT BEEN EXECUTED, THE RESULTS MAY HAVE UNDER-OR-OVER COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY. SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFIT OR LOSSES SIMILAR TO THOSE SHOWN. Earnings Disclaimer: Our website, blogs and emails use affiliate and advertising programs for monetization, which means when you open, read, click on ads or links, will result in a commission that is credited to our company. Compliance: All header and reply-to information is accurate; you may reply directly to this email or send your reply to the physical address or email listed below. Subject lines reflect the content of the email and the email is clearly identified as an advertisement. All opt-outs are automatically honored and managed by the system. When profiling a specific company / stock or publicly traded company: 7322437 Canada Inc (DBA as Financial Media Marketing) has been retained by a third party to perform promotional and advertising services for a limited time with respect to the company we are profiling or discussing, In exchange for such services we have or will receive cash compensation from the third party. Questions regarding this may be sent to admin@financialmediamarketing.com Any information regarding a company profiled or discussed on this website or email is provided from public sources. And we make no representations, warranties or guarantees as to the accuracy or completeness of the information provided or discussed. Our Principals, employees or affiliates may have a position or effect transactions in the securities described herein (or options thereon) and /or otherwise employ trading strategies that may be consistent or inconsistent with the provided strategies. Why are you receiving this email: You are receiving this email because you are subscribed and have requested to receive newsletters from Financial Media Marketing. Please note that Financial Media Marketing will deliver emails to your from several or all of our brands, which will show as different From Names in the emails you receive. You can [click here]( for a list of all our newsletter publications and From Names from which you will receive emails. Contact: For more information please contact us directly: 7322437 Canada Inc (Financial Media Marketing), 330 Av Avro, Pointe-Claire, QC, H9R 5W5. [Our privacy policy can be found here]( If you no longer want to receive any email from us, you can remove yourself from ALL newsletters using [this form](. Your unique contact ID 605e5beb44bb0333ab8b5d02. [Today is]( Wednesday. In order to unsubscribe from this mailing list, please click [here](